JLJonathan Langdon

Jonathan Langdon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jonathan Langdon has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Adjusted Risk Stratification of Indeterminate Thyroid Nodules Using the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI‐RADS)

    by Jessica Zhao, Rita Abi‐Raad, Sara I. Pai, Jonathan Langdon, Minhua Wang, Guoping Cai, John Sinard, Adebowale J. Adeniran, Sanhong Yu

    Background: The TI‐RADS guides the initial management of thyroid nodules, but the malignancy risk across different categories of cytologically indeterminate thyroid nodules (CITNs), particularly AUS and FN, remains unclear. Methods: We reviewed thyroid FNA specimens diagnosed as AUS or FN with TI‐RADS scores of 3, 4, or 5 from 2017 to 2025. Clinical data, molecular results, and surgical outcomes were analyzed. Results: A total of 919 CITNs were identified: 304 with TI‐RADS 3, 454 with TI‐RADS 4, and 161 with TI‐RADS 5. In the absence of molecular alterations, the risk of malignancy (ROM) was low for AUS and FN in both TI‐RADS 3 and 4 categories (< 10%). In contrast, TI‐RADS 5 nodules diagnosed as AUS or FN had the highest ROM (56%). ROM similarly increased with the TI‐RADS score. For AUS, ROM was 14% (TI‐RADS 3), 31% (TI‐RADS 4), and 60% (TI‐RADS 5). For FN, ROM increased from 26% to 44% to 57% across TI‐RADS 3, 4, and 5, respectively. Notably, even AUS nodules without detectable mutations had a high ROM of 44% in TI‐RADS 5, compared to 10% and 15% in TI‐RADS 3 and 4, respectively. Conclusion: Our findings demonstrate distinctive ROMs among AUS and FN stratified by TI‐RADS category and underscore the variable utility of molecular testing. TI‐RADS 5 CITNs carry a significantly higher ROM even in the absence of molecular alterations, suggesting the importance of combining TI‐RADS and TBSRTC.

  • Non‐invasive Vascular Laboratory Evaluation of the Upper Extremity

    by Jonathan Langdon, Leslie M Scoutt, Gowthaman Gunabushanam

    A wide range of vascular pathologies can lead to upper extremity ischemia, including atherosclerotic disease, complications following arterial bypass graft, steal from hemodialysis fistula or graft, trauma including iatrogenic injury, vascular compression syndromes, collagen vascular disorders and vasospasm. Non‐invasive vascular laboratory testing can be helpful in diagnosis as well as follow‐up to assess disease progression and response to therapy. In this article, the technique and interpretation of physiological testing studies such as the wrist brachial index, digital brachial indices, segmental pressure measurements and pulse volume recordings are reviewed. Demonstrative clinical cases are provided with Doppler ultrasound, CT angiography, and angiography correlation.

  • The Utility of Elastography in Discriminating Stages of Liver Fibrosis and Risk Stratification in Patients With Primary Sclerosing Cholangitis: A Systematic Review

    by Payam Hashemi, James L. Boyer, Jonathan H. Langdon

    Background: Primary sclerosing cholangitis (PSC) is a chronic autoimmune disease involving inflammation in the liver and biliary system, manifesting as biliary strictures and cholestasis, and leading to hepatic fibrosis. Due to variable patterns of fibrosis, precise criteria for risk stratification of these patients have yet to be determined. Elasticity‐based methods are widely used to estimate the stage of liver fibrosis in PSC. Purpose: To review the role of different modalities of quantitative elastography in relation to the clinical and fibrosis biomarkers of PSC for the diagnosis and prognosis of this disease. Study Type: Systematic Review: Population or subjects or phantom or specimen or animal model: We conducted a systematic review, adhering to the PRISMA guidelines, and searched PubMed and found 24 articles on the performance of elastography techniques in PSC. Assessment: We qualitatively evaluated methodological limitations including patient selection, reference standard, elasticity acquisition protocols, and outcome definitions. Statistical Tests: N/A. Results: Based on our review, magnetic resonance elastography (MRE) performs better than vibration controlled transient elastography (VCTE), point shear‐wave elastography (p‐SWE), and acoustic radiation force impulse (ARFI) in prediction of poor clinical outcomes in patients with PSC. MRE, an operator‐independent technique, estimates liver stiffness by averaging nearly the total liver volume. Compared with ultrasound‐based elastography, MRE has a lower technical failure rate in assessment of liver fibrosis. Liver stiffness determined by MRE is also correlated with clinical scores such as Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) and Mayo Risk Score (MRS) in patients with PSC. Data Conclusion: Of the elastography methods reviewed, MRE appears to be a preferred modality for staging liver fibrosis and risk stratification of patients with PSC, whereas ultrasound‐based techniques like VCTE are more accessible but might be less accurate. Further studies are warranted to assess the diagnostic and prognostic performance of the various elastography techniques in patients with PSC. Level of Evidence: 5. Technical Efficacy Stage: 5.


  • Imaging of Trauma in Pregnant Patients

    by Jonathan H. Langdon, Nathan Chai, Akash Patel, Scott D. Steenburg, Malak Itani, Douglas S. Katz, Mariam Moshiri, Margarita V. Revzin

    Trauma in pregnancy is complicated by the need for simultaneous care of the mother and fetus as well as prompt diagnosis and treatment, requiring radiologists to have specific knowledge of appropriate imaging methods and findings.


  • Renal transplant ultrasound: assessment of complications and advanced applications

    by Jonathan Langdon, Kedar Sharbidre, Matthew S. Garner, Michelle Robbin, Leslie M. Scoutt

    Renal transplantation is the most commonly performed solid organ transplant procedure. Monitoring renal transplants with ultrasound is a critical component in the management of transplant patients both in the immediate aftermath of surgery and longitudinally. Many complications are detectable via ultrasound evaluation with relative prevalence dependent on the time since surgery. It is critical for the practicing radiologist to recognize these complications to help guide appropriate treatment. Fundamental understanding of the procedure, including various surgical techniques is of great importance. In this article, the sonographic findings of the most common postoperative and long-term complications of renal transplantation are reviewed. As complications are highly related to surgical technique, the most common surgical techniques are presented first. Comprehensive ultrasound evaluation of the allograft is discussed next, followed by extensive review of the ultrasound findings of common complications. Finally, select recent advances in ultrasound are presented with their current and potential applications to renal transplant evaluation.


  • Residual Ultrasound-Enhancing Agents Mimicking Portal Venous Gas

    by Ryan Bitar, Jonathan Langdon, Manroop Kaur, Ian Bs Crandall, Robert McNamara, Margarita Revzin

    Sonographic detection of mobile echogenic foci within the main portal vein and its branches or within the liver parenchyma extending along the portal triads to the periphery of the liver is an alarming finding that has been associated with portal venous gas in the setting of bowel ischemia. Ultrasound-enhancing agents (UEAs) have been widely utilized in abdominal ultrasound for evaluation of organ neoplasms and vascular patency as well as in echocardiography for the evaluation of cardiac function. The appearance of UEAs on abdominal ultrasound can resemble gas like that seen in the portal venous system and liver in patients with bowel ischemia; therefore, UEA residuals should always be a part of the differential diagnosis of echogenic foci when seen on abdominal ultrasounds with preceding recent UEA administration. In this observational study, we present a series of cases with suspected portal venous gas suspicious for bowel ischemia that turned out to be a result of residual or persistent UEA from the recent contrast-enhanced echocardiography. Discussion of this phenomenon and its potential explanation is provided.

  • Delayed cancer diagnosis in the pregnant patient: navigating a complex medical and ethical dilemma

    by Margarita V. Revzin, Nadia Solomon, Jonathan Langdon, Ferenc Czeyda-Pommersheim, Christine O. Menias

    Prompt diagnosis of cancer in pregnancy is necessary to ensure timely management and improve outcomes. However, there are a several reasons why diagnosis may be delayed in pregnancy. Three major contributors to delayed diagnosis and treatment are patient delay, provider delay, and referral delay. This article aims to (1) increase physician awareness of this problem by providing a detailed review of the main culprits of delayed diagnosis and treatment of cancer in the pregnant patient, (2) discuss the complex ethical issues at hand in these cases, and (3) provide suggestions on how to better address such cases with the goal of improving patient outcomes.


  • Thyroid cancer in pregnancy: diagnosis, management, and treatment

    by Jonathan Langdon, Akshya Gupta, Kedar Sharbidre, Ferenc Czeyda-Pommersheim, Margarita Revzin

    The evaluation and management of cancer during pregnancy requires special care to assure the health and safety of both the mother and fetus. The diagnosis and treatment of thyroid cancer in the non-pregnant patient often involves radioactive iodine exposure. However, radioactive iodine is contraindicated in pregnancy and surgical interventions pose risks to both the mother and fetus. Thus, the management of thyroid cancer during pregnancy is a unique clinical challenge. In this review, we discuss the imaging of thyroid nodules during pregnancy, including the role of CT, MRI, and nuclear Imaging, as well as that of Ultrasound and FNA. The staging and prognosis are discussed along with the management, treatment, and surveillance of thyroid cancer in pregnancy. Finally, the risks to the fetus through treatment are examined. Case examples are provided with an emphasis on the appropriate direction of care from a radiologist’s perspective.